![Kevin B. Bacon](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kevin B. Bacon
Vorstandsvorsitzender bei
Abcentra, Inc.
Profil
Kevin B. Bacon was the founder of Actimis Pharmaceuticals, Inc. (founded in 2004, Chief Scientific Officer) and Axikin Pharmaceuticals, Inc. (founded in 2008, President, Director & Chief Scientific Officer).
Current jobs include Chief Executive Officer at Abcentra, Inc. (since 2020), President, Chief Executive Officer & Director at Sequoia Vaccines, Inc. (since 2023), and President, Chief Executive Officer & Director at Sequoia Sciences, Inc. Former jobs include Chief Executive Officer at Raft Pharmaceuticals LLC (2018-2020), Associate Director at Neurocrine Biosciences, Inc., Principal at Bayer AG (1999-2004), Vice President-Respiratory Diseases Research at Bayer HealthCare AG (1999-2004), and Principal at DNAX Research, Inc. Education includes a doctorate from the University of London and an undergraduate degree from King's College London.
Aktive Positionen von Kevin B. Bacon
| Unternehmen | Position | Beginn |
|---|---|---|
Abcentra, Inc.
 Abcentra, Inc. Miscellaneous Commercial ServicesCommercial Services Develops oxidized LDL blocking therapeutics for cardiovascular inflammation treatment | Vorstandsvorsitzender | 15.06.2020 |
Sequoia Vaccines, Inc.
 Sequoia Vaccines, Inc. BiotechnologyHealth Technology Develops and sells vaccines & small molecules for treating urinary tract and bacterial infections & cancers | Vorstandsvorsitzender | 01.04.2023 |
Sequoia Sciences, Inc.
 Sequoia Sciences, Inc. Pharmaceuticals: OtherHealth Technology Develops new medicines for the treatment of bacterial infections and cancers | Vorstandsvorsitzender | - |
Ehemalige bekannte Positionen von Kevin B. Bacon
| Unternehmen | Position | Ende |
|---|---|---|
Raft Pharmaceuticals LLC | Vorstandsvorsitzender | 01.01.2020 |
Actimis Pharmaceuticals, Inc.
 Actimis Pharmaceuticals, Inc. BiotechnologyHealth Technology Provides pharmaceutical research and development services | Gründer | 01.02.2018 |
Axikin Pharmaceuticals, Inc.
 Axikin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes small molecule therapeutics | Gründer | 01.01.2017 |
| BAYER AG | Corporate Officer/Principal | 01.01.2004 |
Bayer HealthCare AG
 Bayer HealthCare AG Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals, healthcare supplements and crop herbicides | Corporate Officer/Principal | 01.01.2004 |
Ausbildung von Kevin B. Bacon
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
68
Beziehungen ersten Grades
12
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 12 |
|---|---|
Neurocrine Biosciences, Inc.
 Neurocrine Biosciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes treatments for neurological, neuroendocrine and neuropsychiatric disorders | Health Technology |
Bayer AG
 Bayer AG Pharmaceuticals: MajorHealth Technology Provides health care, nutrition and high-tech material services | Health Technology |
Actimis Pharmaceuticals, Inc.
Actimis Pharmaceuticals, Inc. BiotechnologyHealth Technology Provides pharmaceutical research and development services | Health Technology |
Axikin Pharmaceuticals, Inc.
Axikin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes small molecule therapeutics | Health Technology |
Bayer HealthCare AG
Bayer HealthCare AG Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals, healthcare supplements and crop herbicides | Health Technology |
University of London
 University of London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
King's College London
 King's College London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
DNAX Research, Inc. | |
Sequoia Sciences, Inc.
Sequoia Sciences, Inc. Pharmaceuticals: OtherHealth Technology Develops new medicines for the treatment of bacterial infections and cancers | Health Technology |
Abcentra, Inc.
Abcentra, Inc. Miscellaneous Commercial ServicesCommercial Services Develops oxidized LDL blocking therapeutics for cardiovascular inflammation treatment | Commercial Services |
Sequoia Vaccines, Inc.
Sequoia Vaccines, Inc. BiotechnologyHealth Technology Develops and sells vaccines & small molecules for treating urinary tract and bacterial infections & cancers | Health Technology |
Raft Pharmaceuticals LLC |
